Top Story

Study suggests less than 1% of acute HCV cases reported to the CDC

Study suggests less than 1% of acute HCV cases reported to the CDC
June 29, 2015

In a new study published in Annals of Internal Medicine, researchers in Massachusetts found that less than 1% of acute cases of hepatitis C virus infection over the course of a decade in Massachusetts were reported to the CDC.

“The incidence of HCV can be likened to an ‘iceberg,’ in that only a fraction of cases — the proverbial ‘tip’ — is visible,” Arthur Kim, MD, division of infectious diseases, Massachusetts General Hospital, said in a press release. “That is due to the minimal symptoms that usually accompany acute HCV and the fragmented care available to those at highest risk, such as those who inject drugs. Many states have limited resources to track and identify HCV cases; and since even Massachusetts, where we have reasonable resources for HCV surveillance, found it difficult to report acute cases during the period we studied, it’s likely that national estimates have been based on inaccurate numbers.”

In the Journals

TE accurate in diagnosing subclinical cirrhosis in patients at risk for HBV-related HCC

June 29, 2015
Researchers in Korea used transient elastography and found it to be useful in identifying subclinical cirrhosis among patients at risk for hepatitis B virus…

China, Taiwan FDAs accept trial applications for IFN-free HCV regimen

June 29, 2015
The China and Taiwan Food and Drug Administrations have accepted clinical trial applications filed by Ascletis Innovation for its interferon-free regimen to treat…

Bristol-Myers Squibb discontinues research for HBV, HIV drugs

June 26, 2015
As their company expands, Bristol Myers-Squibb will be discontinuing its research efforts in virology, which includes early research of certain drugs for hepatitis B…
CME
HCV VOICE

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
Meeting News Coverage Video
thumbnail for video 3899432251001

New HCV treatments could reduce mortality, but increase costs by billions

November 19, 2014
BOSTON – In this video exclusive from The Liver Meeting, David B. Rein, PhD, MPA, of the National Opinion…
More »
Arthur Kim In the Journals

Study suggests less than 1% of acute HCV cases reported to the CDC

June 29, 2015
In a new study published in Annals of Internal Medicine, researchers in Massachusetts found that less than 1% of acute cases of hepatitis C virus…
In the Journals

TE accurate in diagnosing subclinical cirrhosis in patients at risk for HBV-related HCC

June 29, 2015
Researchers in Korea used transient elastography and found it to be useful in identifying subclinical cirrhosis among patients at risk for hepatitis…

China, Taiwan FDAs accept trial applications for IFN-free HCV regimen

June 29, 2015
The China and Taiwan Food and Drug Administrations have accepted clinical trial applications filed by Ascletis Innovation for its interferon-free…

Bristol-Myers Squibb discontinues research for HBV, HIV drugs

June 26, 2015
As their company expands, Bristol Myers-Squibb will be discontinuing its research efforts in virology, which includes early research of certain drugs…
HBV may lead to more aggressive form of HCC than HCV Meeting News Coverage

HBV may lead to more aggressive form of HCC than HCV

June 25, 2015
CHICAGO — Patients with hepatitis B virus infection were more likely to develop hepatocellular carcinoma at a younger age and have a more…

TURQUOISE-III: Treatment yields 100% SVR12 for HCV genotype 1b

June 25, 2015
Phase 3 clinical results showed 100% of patients with hepatitis C virus infection genotype 1b with compensated liver cirrhosis reached a sustained…
In the Journals

PEG-IFN treatment yields high SVR in children with HCV

June 23, 2015
In a systematic review, children with hepatitis C virus infection treated with pegylated interferon-alfa with ribavirin yielded higher sustained…
In the Journals

Deep sequencing creates distinction between acute and chronic HCV

June 23, 2015
Deep sequencing accurately differentiated between acute and chronic hepatitis C virus infection, according to published study data. “Deep…
In the Journals

HDV risk found to be prevalent in IDUs in Taiwan

June 22, 2015
Injection drug users in Taiwan, including those with HIV, were found to have an increased risk of hepatitis D virus infection, despite the…
In the Journals

Data highlight need for support of HBV immunization programs overseas

June 19, 2015
Active and past hepatitis B virus infection was identified among refugee groups from Bhutan, Burma, Iraq and other countries — the rates varied…
More Headlines »
morganatic-roan